Schedule 13G ownership disclosure
ASTRIA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 04635X102
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Integrated Core Strategies (US) LLC
Shares: 1,960,135.00 · Class: 3.5%
- Millennium Management LLC
Shares: 1,994,503.00 · Class: 3.5%
- Millennium Group Management LLC
Shares: 1,994,503.00 · Class: 3.5%
- Israel A. Englander
Shares: 1,994,503.00 · Class: 3.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-006680
- Form type
- SCHEDULE 13G/A
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Jan 28, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership